CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 157 filers reported holding CARA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $2,085,000 | -94.4% | 146,135 | -91.4% | 0.02% | -94.3% |
| Q1 2021 | $36,957,000 | +31.9% | 1,702,308 | -8.1% | 0.42% | +44.4% |
| Q4 2020 | $28,012,000 | +15.5% | 1,851,443 | -2.8% | 0.29% | +2.1% |
| Q3 2020 | $24,250,000 | -31.3% | 1,905,680 | -7.7% | 0.29% | -41.2% |
| Q2 2020 | $35,314,000 | +49.6% | 2,065,153 | +15.6% | 0.49% | +21.1% |
| Q1 2020 | $23,607,000 | +61.3% | 1,787,062 | +96.7% | 0.40% | +105.6% |
| Q4 2019 | $14,637,000 | +113.6% | 908,570 | +142.3% | 0.20% | +127.9% |
| Q3 2019 | $6,854,000 | -51.2% | 374,948 | -42.6% | 0.09% | -50.6% |
| Q2 2019 | $14,034,000 | +64.8% | 652,742 | +50.4% | 0.17% | +75.8% |
| Q1 2019 | $8,514,000 | +64.5% | 433,967 | +9.0% | 0.10% | +26.9% |
| Q4 2018 | $5,177,000 | -56.8% | 398,196 | -20.5% | 0.08% | -23.5% |
| Q3 2018 | $11,989,000 | +3.6% | 500,581 | -17.2% | 0.10% | +18.6% |
| Q2 2018 | $11,572,000 | – | 604,272 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,204,449 | $10,824 | 1.35% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,233,000 | $6,054,030 | 1.14% |
| Chescapmanager LLC | 1,160,392 | $5,698 | 0.90% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,732,375 | $8,505,961 | 0.22% |
| XTX Topco Ltd | 107,610 | $528,365 | 0.11% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 84,530 | $415,042 | 0.08% |
| PINNACLE ASSOCIATES LTD | 679,413 | $3,335,918 | 0.07% |
| PDT Partners, LLC | 102,010 | $500,869 | 0.07% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,370 | $9,797,267 | 0.05% |
| AXQ CAPITAL, LP | 27,760 | $136,302 | 0.05% |